Racura Oncology Ltd (ASX:RAC)
Australia · Delayed Price · Currency is AUD 2.610
-0.150 (-5.43%)
May 18, 2026, 4:10 PM AEST
Racura Oncology Market Cap
Racura Oncology has a market cap or net worth of 516.39 million as of May 18, 2026. Its market cap has increased by 151.91% in one year.
Market Cap
516.39M
Enterprise Value
495.45M
Revenue
3.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.61
Market Cap Chart
Since July 13, 2016, Racura Oncology's market cap has increased from 12.64M to 516.39M, an increase of 3,986.26%. That is a compound annual growth rate of 45.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 15, 2026 | 516.39M | 4.61% |
| Dec 31, 2025 | 493.64M | 110.49% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 1.63B |
| PYC Therapeutics | 1.41B |
| Clarity Pharmaceuticals | 1.08B |
| Opthea | 738.77M |
| Clinuvel Pharmaceuticals | 477.55M |
| Starpharma Holdings | 261.11M |
| Tetratherix | 252.81M |
| Orthocell | 225.19M |